4//SEC Filing
MACROCHEM CORP 4
Accession 0001349083-08-000011
CIK 0000743884operating
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 3:37 PM ET
Size
6.0 KB
Accession
0001349083-08-000011
Insider Transaction Report
Form 4
MACROCHEM CORPMACM.OB
Jeffrey B Davis
Director
Transactions
- Other
Common Stock
2008-04-25+2,138,076→ 2,973,693 total(indirect: By LLC)
Footnotes (2)
- [F1]Pro rata distribution of shares of issuer held by Virium Holdings, Inc. of which reporting person was a shareholder. Virium Holdings, Inc. received such shares of issuer as merger consideration in connection with the Agreement and Plan of Merger dated April 18, 2008, by and among issuer, VRM Acquisition, LLC, a Delaware limited liability company and a wholly-owned subsidiary of issuer, Virium Holdings, Inc. and Virium Pharmaceuticals Inc., a New York corporation and wholly-owned subsidiary of Virium Holdings, Inc., pursuant to which VRM Acquisition LLC merged with and into Virium Pharmaceuticals Inc. Virium Holdings, Inc. was dissolved on April 25, 2008.
- [F2]Lake End Capital LLC is the direct beneficial owner of these securities. Jeffrey B. Davis is the managing member of Lake End Capital LLC.
Documents
Issuer
MACROCHEM CORP
CIK 0000743884
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000743884
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 3:37 PM ET
- Size
- 6.0 KB